Your browser doesn't support javascript.
loading
Discovery of Targets for Immune-Metabolic Antitumor Drugs Identifies Estrogen-Related Receptor Alpha.
Sahu, Avinash; Wang, Xiaoman; Munson, Phillip; Klomp, Jan P G; Wang, Xiaoqing; Gu, Shengqing Stan; Han, Ya; Qian, Gege; Nicol, Phillip; Zeng, Zexian; Wang, Chenfei; Tokheim, Collin; Zhang, Wubing; Fu, Jingxin; Wang, Jin; Nair, Nishanth Ulhas; Rens, Joost A P; Bourajjaj, Meriem; Jansen, Bas; Leenders, Inge; Lemmers, Jaap; Musters, Mark; van Zanten, Sanne; van Zelst, Laura; Worthington, Jenny; Liu, Jun S; Juric, Dejan; Meyer, Clifford A; Oubrie, Arthur; Liu, X Shirley; Fisher, David E; Flaherty, Keith T.
Afiliação
  • Sahu A; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Wang X; Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, Colorado.
  • Munson P; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Klomp JPG; State Key Laboratory of Medical Molecular Biology, Department of Biochemistry and Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Wang X; Department of Medicine and Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Gu SS; Lead Pharma, Kloosterstraat, Oss, the Netherlands.
  • Han Y; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Qian G; Department of Cardiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
  • Nicol P; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Zeng Z; School of Life Sciences and Technology, Tongji University, Shanghai, China.
  • Wang C; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Tokheim C; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Zhang W; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Fu J; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Wang J; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Nair NU; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Rens JAP; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Bourajjaj M; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Jansen B; Cancer Data Science Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Leenders I; Lead Pharma, Kloosterstraat, Oss, the Netherlands.
  • Lemmers J; Lead Pharma, Kloosterstraat, Oss, the Netherlands.
  • Musters M; Lead Pharma, Kloosterstraat, Oss, the Netherlands.
  • van Zanten S; Lead Pharma, Kloosterstraat, Oss, the Netherlands.
  • van Zelst L; Lead Pharma, Kloosterstraat, Oss, the Netherlands.
  • Worthington J; Lead Pharma, Kloosterstraat, Oss, the Netherlands.
  • Liu JS; Lead Pharma, Kloosterstraat, Oss, the Netherlands.
  • Juric D; Lead Pharma, Kloosterstraat, Oss, the Netherlands.
  • Meyer CA; Axis Bioservices, Coleraine, United Kingdom.
  • Oubrie A; Department of Statistics, Harvard University, Cambridge, Massachusetts.
  • Liu XS; Department of Medicine and Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Fisher DE; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Flaherty KT; Lead Pharma, Kloosterstraat, Oss, the Netherlands.
Cancer Discov ; 13(3): 672-701, 2023 03 01.
Article em En | MEDLINE | ID: mdl-36745048

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Melanoma / Antineoplásicos Limite: Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Melanoma / Antineoplásicos Limite: Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos